|
UGDH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.056400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.775900E-02 |
| Normal-vs-Stage2 |
6.651600E-01 |
| Normal-vs-Stage3 |
1.743820E-01 |
| Normal-vs-Stage4 |
8.414500E-02 |
| Stage1-vs-Stage2 |
2.077600E-01 |
| Stage1-vs-Stage3 |
1.419850E-02 |
| Stage1-vs-Stage4 |
5.908100E-02 |
| Stage2-vs-Stage3 |
4.978800E-01 |
| Stage2-vs-Stage4 |
1.087580E-01 |
| Stage3-vs-Stage4 |
1.632210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.254400E-01 |
| Normal-vs-AfricanAmerican |
3.485000E-01 |
| Normal-vs-Asian |
4.756400E-01 |
| Caucasian-vs-AfricanAmerican |
5.695600E-01 |
| Caucasian-vs-Asian |
3.368000E-01 |
| AfricanAmerican-vs-Asian |
3.831400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.333770E-01 |
| Normal-vs-Female |
7.863700E-02 |
| Male-vs-Female |
6.796400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.174000E-01 |
| Normal-vs-Extreme_Weight |
1.007060E-04 |
| Normal-vs-Obese |
3.542000E-01 |
| Normal-vs-Extreme_Obese |
9.980600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.437800E-02 |
| Normal_Weight-vs-Obese |
9.816600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.955800E-01 |
| Extreme_Weight-vs-Obese |
1.707750E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.452400E-01 |
| Obese-vs-Extreme_Obese |
6.989600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.742040E-01 |
| Normal-vs-Age(41-60Yrs) |
7.322000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.562200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.319800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.492550E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.469900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.077800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.902400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.078200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.890180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.56239999999208E-05 |
| Normal-VS-Type2 PRCC |
2.211600E-01 |
| Normal-VS-KIRP CIMP |
7.217000E-03 |
| Normal-VS-Unclassified PRCC |
3.079600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.443600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.159100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.929600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.239600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.164400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.484200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.594000E-01 |
| Normal-vs-N1 |
1.076430E-02 |
| Normal-vs-N2 |
3.147400E-01 |
| N0-vs-N1 |
7.221200E-03 |
| N0-vs-N2 |
4.753800E-02 |
| N1-vs-N2 |
6.498200E-01 |
|
|
